{"id":"u14eFYfxfY7LofNnlkGD","title":"A Great Company Is Not Always a Great Stock: What History's Largest IPO Has to Assume","slug":"a-great-company-is-not-always-a-great-stock-what-historys-largest-ipo-has-to-assume","content":"<p><strong>The Setup</strong></p>\n<p>On Friday, June 12, SpaceX began trading on the Nasdaq under the ticker SPCX. The offering priced the night before at $135 per share across roughly 555.6 million shares, raising on the order of $75 billion — comfortably the largest initial public offering in history, eclipsing Saudi Aramco's 2019 debut several times over. The stock opened higher, climbed through the session, and closed up about 19% near $161. By the closing bell, the company's market capitalization stood north of $2 trillion. In an unusual structural twist, the offering reserved as much as 30% of shares for retail investors — roughly three to six times the typical allocation.</p>\n<p>For most people watching, the reflexive question was: <em>is SpaceX a great company?</em> And the consensus answer is yes. Reusable orbital rockets, a launch cadence no competitor approaches, and a satellite-internet network with more than 9,600 satellites in orbit make for one of the most genuinely impressive engineering organizations of the era.</p>\n<p>But \"is this a great company?\" is the wrong question for an investor. The right one is harder and far less discussed: <em>what does the future have to deliver to justify paying this price today?</em> Those are not the same question, and the gap between them is where a great deal of permanent capital loss has historically occurred.</p>\n<p><strong>The Analysis</strong></p>\n<p><strong>A great company is not a great stock</strong></p>\n<p>The quality of a business and the quality of an investment are routinely conflated, and the bridge between them is always price. A wonderful business purchased at a price that already assumes a wonderful future offers very little margin for error — everything has to go right just to earn an ordinary return. A merely good business purchased at a deeply discounted price can be an excellent investment, because the bar it has to clear is low. This is the oldest discipline in fundamental investing, and it is also the one most reliably abandoned during an IPO, precisely because the narrative is loudest and the price has the least history behind it.</p>\n<p>The structure of an IPO compounds the challenge for a buyer. The people selling — early investors, insiders, the company itself — generally choose the moment of sale, and they know the business far better than the public buying it. That information asymmetry does not make an IPO a bad investment. It does mean the buyer is, by default, on the less-informed side of the table and should demand a correspondingly clear-eyed view of what they are paying for.</p>\n<p><strong>What the filing actually shows</strong></p>\n<p>SpaceX's S-1, filed in May, offered the first real public look at the financials beneath the story. In 2025 the company generated about $18.7 billion in revenue, up roughly 30% year over year — a large and fast-growing business by any standard. It also reported a net loss of about $4.9 billion, and free cash flow of roughly negative $9 billion, as a modest amount of operating cash was overwhelmed by heavy investment in satellites, Starship development, and AI compute.</p>\n<p>Underneath the consolidated numbers sits a more revealing picture. Starlink, the satellite-internet segment, produced about $11.4 billion of revenue — 61% of the total — grew around 50%, and earned roughly $4.4 billion in operating income. It is the engine, and currently the only segment turning a meaningful profit. The launch business and the AI segment both lost money in 2025. So the enterprise being valued north of $2 trillion is, financially, one exceptional and highly profitable franchise subsidizing ambitious, capital-hungry bets that have not yet paid off.</p>\n<p><strong>The right tool: reverse the question</strong></p>\n<p>Most investors approach a stock by trying to forecast its future and arrive at a \"target price.\" For a company like this — pre-profit on a consolidated basis, with multiple businesses at wildly different stages — that exercise quickly becomes an exercise in spreadsheet imagination.</p>\n<p>There is a more disciplined alternative, developed by Alfred Rappaport and Michael Mauboussin in their work on what they call <em>expectations investing</em>: take the market price as given, and solve backward for the expectations it implies. A stock price is not just a number to react to. It is a forecast — a compressed set of assumptions about growth, margins, and returns on capital — and the investor's job is to judge whether those embedded assumptions are conservative, reasonable, or heroic.</p>\n<p><strong>What must be true for $2 trillion</strong></p>\n<p>Consider the rough arithmetic, offered purely to illustrate the method rather than to render any verdict on the security. At a valuation north of $2 trillion against $18.7 billion of revenue, the business trades at more than 100 times its 2025 sales. Mature, high-quality enterprises are ultimately valued on the cash they generate. If one imagines SpaceX someday valued like a great cash-generative compounder — say, 20 to 30 times free cash flow — then justifying a $2 trillion price tag implies the company eventually produces somewhere in the range of $70 billion to $100 billion of annual free cash flow.</p>\n<p>Today that figure is negative. To reach, say, $80 billion of free cash flow at a healthy mid-twenties-percent margin, the company would need revenue north of $300 billion — roughly sixteen times what it earns today. Growing from $18.7 billion to $300 billion inside a decade requires compounding revenue at more than 30% per year, every year, while simultaneously converting today's losses into best-in-class profitability.</p>\n<p>None of that is a prediction, and none of it is impossible — Starlink's global penetration, a step-change in Starship launch economics, and entirely new markets could all contribute. The point of the exercise is different. It surfaces the bar. The price already embeds an extraordinarily optimistic outcome, which means an investor buying at this level is not being paid much to be right and is exposed to real downside for being merely \"less wrong\" — for a company that succeeds impressively, but on a timeline or scale short of what the price assumes.</p>\n<p>That reframing is the entire value of the tool. You do not have to answer the unanswerable question, <em>\"Will SpaceX succeed?\"</em> You have to answer a narrower and far more tractable one: <em>\"Are the expectations embedded in today's price ones I would willingly underwrite with my own capital?\"</em> Often the most useful output is the recognition that the optimistic case is already in the price — leaving little reward for the patient and considerable risk for the impatient.</p>\n<p><strong>The Implication</strong></p>\n<p>For a long-term investor with the discipline to wait, the frenzy around a landmark IPO is exactly the environment in which this approach earns its keep. A genuinely exciting company, a brand-new listing, heavy retail participation, and a price that already discounts a heroic future together create an asymmetry that frequently favors patience over action.</p>\n<p>This is not a claim that the price is wrong, nor a prediction that it will fall. It is a statement about process. Great businesses do sometimes become great investments — often later, when the initial enthusiasm fades and expectations reset to a level a buyer can underwrite with a genuine margin of safety. The work in the meantime is unglamorous: keep the company on the list, understand it deeply enough to know what you would actually pay, and let price rather than narrative be the thing that triggers a decision. It also means being honest about the edge of one's competence — a business spanning launch economics, satellite networks, and frontier AI is genuinely hard to underwrite, and difficulty is itself information.</p>\n<p><strong>The Takeaway</strong></p>\n<p>The question that matters is never simply <em>\"Is this a great company?\"</em> It is <em>\"What does this price require the future to deliver — and would I take the other side of that bet?\"</em> A great company can be a poor investment at the wrong price, and the most reliable way to tell the difference is to read the expectations the market has already built in, and decide — soberly, and in advance — whether you would sign your name to them.</p>","excerpt":"SpaceX went public at more than a $2 trillion valuation on its first day of trading — and whether it is a great company and whether it is a great investment at that price are two entirely different questions, with a disciplined way to tell them apart.","author":"Christopher Stark","authorId":"s8BO5Lorptnecyzv2aFS","featuredImage":null,"readingTime":7,"scheduledPublishAt":null,"createdBy":{"uid":"ZtFFCCvaN2gDC3LUQpw8AkIGxhG2","email":"chris@thestarkfund.com"},"updatedBy":{"uid":"ZtFFCCvaN2gDC3LUQpw8AkIGxhG2","email":"chris@thestarkfund.com"},"createdAt":{"_seconds":1781723943,"_nanoseconds":304000000},"metaDescription":"Uncover why a great company doesn't always translate to a great stock, using history's largest IPO as a case study. Understand valuation's true impact on return","tags":["ipo analysis","valuation","equity research","spacex"],"publishDate":{"_seconds":1781654400,"_nanoseconds":0},"publishedAt":{"_seconds":1781724317,"_nanoseconds":172000000},"status":"published","updatedAt":{"_seconds":1781724317,"_nanoseconds":172000000}}